Literature DB >> 19430891

Frame-based stereotaxy in a frameless era: current capabilities, relative role, and the positive- and negative predictive values of blood through the needle.

Christopher M Owen1, Mark E Linskey.   

Abstract

INTRODUCTION: In the modern era of frameless stereotaxis (FL), the role of frame-based (FB) stereotactic needle biopsy is evolving.
METHODS: Retrospective review of prospective database of 106 lesions in 91 consecutive patients undergoing FB stereotactic needle biopsy with a systematic "geologic core" technique by a single surgeon. Diagnostic accuracy was calculated comparing biopsy diagnosis with final pathology in 11 patients who underwent subsequent surgical resection. All instances of intra-operative bleeding through the needle were prospectively noted and compared with post-biopsy CT scan. Lesions were classified as risky for FL technique if they were (1) infratentorial or pineal, (2) within 10 mm of the circle of Willis or root of the Sylvian fissure, or (3) within 10 mm of deep cerebral veins.
RESULTS: Diagnostic yield was 94%. Diagnostic accuracy was 91%. Of 18 lesions involving the corpus callosum, 13 (72.2%) were GBM 2 were anaplastic astrocytoma, and 1 each were found to be anaplastic oligodendroglioma, primary central nervous system lymphoma (PCNSL) and tumescent MS. Of 25 multifocal lesions, malignant primary brain tumor was diagnosed in 17 (68%) (11 GBM, 3 PCNSL, 2 anaplastic ologodendroglioma, and 1 anaplastic astrocytoma). Mortality was 0%. Three patients developed temporary neurologic deficits and one had permanent deficit. Absence of persistent blood through the biopsy needle had a negative predicative value of 98.8% for subsequent neuroimaging blood >5 mm diameter. According to our criteria, 80% of patients would have been candidates for FL biopsy.
CONCLUSIONS: Stereotactic biopsy is an effective, safe and important technique for histologic diagnosis of brain lesions, particularly for multifocal and corpus callosum lesions. Post-biopsy CT can be safely reserved for patients who demonstrate persistent bleeding through the biopsy needle. FB stereotaxy remains an important technique for the 20% with small or deep seated lesions or when it is advantageous to avoid an incision, a burr hole or general anesthesia.

Entities:  

Mesh:

Year:  2009        PMID: 19430891     DOI: 10.1007/s11060-009-9871-y

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  32 in total

1.  Stereotactic biopsies guided by an optical navigation system: technique and clinical experience.

Authors:  P Grunert; J Espinosa; C Busert; M Günthner; R Filippi; S Farag; N Hopf
Journal:  Minim Invasive Neurosurg       Date:  2002-03

2.  Frameless image-guided stereotactic brain biopsy procedure: diagnostic yield, surgical morbidity, and comparison with the frame-based technique.

Authors:  Graeme F Woodworth; Matthew J McGirt; Amer Samdani; Ira Garonzik; Alessandro Olivi; Jon D Weingart
Journal:  J Neurosurg       Date:  2006-02       Impact factor: 5.115

3.  Stereotactic brain biopsy: An audit of sampling reliability in a clinical case series.

Authors:  N Shastri-Hurst; M Tsegaye; D K Robson; J S Lowe; D C Macarthur
Journal:  Br J Neurosurg       Date:  2006-08       Impact factor: 1.596

4.  Accuracy of registration methods in frameless stereotaxis.

Authors:  P A Helm; T S Eckel
Journal:  Comput Aided Surg       Date:  1998

5.  A phantom study to assess the accuracy of stereotactic localization, using T1-weighted magnetic resonance imaging with the Leksell stereotactic system.

Authors:  L Walton; A Hampshire; D M Forster; A A Kemeny
Journal:  Neurosurgery       Date:  1996-01       Impact factor: 4.654

6.  Quantification of true in vivo (application) accuracy in cranial image-guided surgery: influence of mode of patient registration.

Authors:  Christopher R Mascott; Jean-Christophe Sol; Philippe Bousquet; Jacques Lagarrigue; Yves Lazorthes; Valérie Lauwers-Cances
Journal:  Neurosurgery       Date:  2006-07       Impact factor: 4.654

7.  Importance of image-guided stereotactic biopsy to confirm diagnosis in an oncological setting.

Authors:  E Arbit; J H Galicich
Journal:  Ann Surg Oncol       Date:  1994-09       Impact factor: 5.344

8.  CT stereotactic biopsy for optimizing the therapy of intracranial processes.

Authors:  F Mundinger
Journal:  Acta Neurochir Suppl (Wien)       Date:  1985

9.  Clinical validation of true frameless stereotactic biopsy: analysis of the first 125 consecutive cases.

Authors:  T S Paleologos; N L Dorward; J P Wadley; D G Thomas
Journal:  Neurosurgery       Date:  2001-10       Impact factor: 4.654

10.  Neuroimaging of acoustic nerve sheath tumors after stereotaxic radiosurgery.

Authors:  M E Linskey; L D Lunsford; J C Flickinger
Journal:  AJNR Am J Neuroradiol       Date:  1991 Nov-Dec       Impact factor: 3.825

View more
  17 in total

1.  Real-time MR-guided brain biopsy using 1.0-T open MRI scanner.

Authors:  Xiangmeng He; Ming Liu; Chao Liu; Jing Fang; Yujun Xu; Ligang Wang; Jianfeng Xiang; Roberto Blanco Sequeiros; Chengli Li
Journal:  Eur Radiol       Date:  2018-06-12       Impact factor: 5.315

2.  Comparative effectiveness of frame-based, frameless, and intraoperative magnetic resonance imaging-guided brain biopsy techniques.

Authors:  Yi Lu; Cecil Yeung; Alireza Radmanesh; Robert Wiemann; Peter M Black; Alexandra J Golby
Journal:  World Neurosurg       Date:  2014-08-01       Impact factor: 2.104

3.  A novel re-attachable stereotactic frame for MRI-guided neuronavigation and its validation in a large animal and human cadaver model.

Authors:  Christine A Edwards; Aaron E Rusheen; Yoonbae Oh; Seungleal B Paek; Joshua Jacobs; Kristen H Lee; Kendall D Dennis; Kevin E Bennet; Abbas Z Kouzani; Kendall H Lee; Stephan J Goerss
Journal:  J Neural Eng       Date:  2018-08-20       Impact factor: 5.379

4.  Diagnostic discrepancies in malignant astrocytoma due to limited small pathological tumor sample can be overcome by IDH1 testing.

Authors:  Betty Y S Kim; Wen Jiang; Jason Beiko; Sujit S Prabhu; Franco DeMonte; Mark R Gilbert; Raymond Sawaya; Kenneth D Aldape; Daniel P Cahill; Ian E McCutcheon
Journal:  J Neurooncol       Date:  2014-04-29       Impact factor: 4.130

5.  Towards improving the safety and diagnostic yield of stereotactic biopsy in a single centre.

Authors:  Ruben Dammers; Joost W Schouten; Iain K Haitsma; Arnaud J P E Vincent; Johan M Kros; Clemens M F Dirven
Journal:  Acta Neurochir (Wien)       Date:  2010-08-01       Impact factor: 2.216

Review 6.  The evolving role of neurological imaging in neuro-oncology.

Authors:  E J Fontana; T Benzinger; C Cobbs; J Henson; S J Fouke
Journal:  J Neurooncol       Date:  2014-08-01       Impact factor: 4.130

7.  5-ALA fluorescence and laser Doppler flowmetry for guidance in a stereotactic brain tumor biopsy.

Authors:  Neda Haj-Hosseini; Johan C O Richter; Peter Milos; Martin Hallbeck; Karin Wårdell
Journal:  Biomed Opt Express       Date:  2018-04-20       Impact factor: 3.732

Review 8.  Clinical trials in neurosurgical oncology.

Authors:  Meghan Murphy; Ian F Parney
Journal:  J Neurooncol       Date:  2014-08-09       Impact factor: 4.130

9.  Fluorescein-assisted stereotactic needle biopsy of brain tumors: a single-center experience and systematic review.

Authors:  Giuseppe Catapano; Francesco Giovanni Sgulò; Vincenzo Seneca; Giuseppina Iorio; Matteo de Notaris; Giuseppe di Nuzzo
Journal:  Neurosurg Rev       Date:  2018-01-30       Impact factor: 3.042

10.  A compact stereotactic system for image-guided surgical intervention.

Authors:  Aaron E Rusheen; Abhijeet S Barath; Abhinav Goyal; J Hudson Barnett; Benjamin T Gifford; Kevin E Bennet; Charles D Blaha; Stephan J Goerss; Yoonbae Oh; Kendall H Lee
Journal:  J Neural Eng       Date:  2020-12-16       Impact factor: 5.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.